These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 9695662)

  • 21. Bone marrow dosimetry using blood-based models for radiolabeled antibody therapy: a multiinstitutional comparison.
    Wessels BW; Bolch WE; Bouchet LG; Breitz HB; Denardo GL; Meredith RF; Stabin MG; Sgouros G;
    J Nucl Med; 2004 Oct; 45(10):1725-33. PubMed ID: 15471841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MIRD pamphlet no. 16: Techniques for quantitative radiopharmaceutical biodistribution data acquisition and analysis for use in human radiation dose estimates.
    Siegel JA; Thomas SR; Stubbs JB; Stabin MG; Hays MT; Koral KF; Robertson JS; Howell RW; Wessels BW; Fisher DR; Weber DA; Brill AB
    J Nucl Med; 1999 Feb; 40(2):37S-61S. PubMed ID: 10025848
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MIRD Pamphlet No. 14 revised: A dynamic urinary bladder model for radiation dose calculations. Task Group of the MIRD Committee, Society of Nuclear Medicine.
    Thomas SR; Stabin MG; Chen CT; Samaratunga RC
    J Nucl Med; 1999 Apr; 40(4):102S-123S. PubMed ID: 10210232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Activity of administered radiopharmaceutical agents and the radiation burden of the Czechoslovak population caused by nuclear medicine].
    Husák V; Rícková H
    Cesk Radiol; 1990 Sep; 44(5):333-9. PubMed ID: 2249311
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 1-11C-methyl-4-piperidinyl-N-butyrate radiation dosimetry in humans by dynamic organ-specific evaluation.
    Virta JR; Tolvanen T; Någren K; Brück A; Roivainen A; Rinne JO
    J Nucl Med; 2008 Mar; 49(3):347-53. PubMed ID: 18287260
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patient dosimetry of intravenously administered 99mTc-annexin V.
    Kemerink GJ; Liem IH; Hofstra L; Boersma HH; Buijs WC; Reutelingsperger CP; Heidendal GA
    J Nucl Med; 2001 Feb; 42(2):382-7. PubMed ID: 11216539
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Whole-body radiation dosimetry of 2-[18F]Fluoro-A-85380 in human PET imaging studies.
    Obrzut SL; Koren AO; Mandelkern MA; Brody AL; Hoh CK; London ED
    Nucl Med Biol; 2005 Nov; 32(8):869-74. PubMed ID: 16253812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Consideration of the ICRP 2006 revised tissue weighting factors on age-dependent values of the effective dose for external photons.
    Lee C; Lee C; Han EY; Bolch WE
    Phys Med Biol; 2007 Jan; 52(1):41-58. PubMed ID: 17183127
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Use of radiopharmaceuticals, radiation burden and radiation risks in examination procedures in nuclear medicine].
    Husák V; Petrová K; Masopust J; Myslivecek M
    Cas Lek Cesk; 1999 May; 138(11):323-8. PubMed ID: 10422342
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Weight-based, low-dose pediatric whole-body PET/CT protocols.
    Alessio AM; Kinahan PE; Manchanda V; Ghioni V; Aldape L; Parisi MT
    J Nucl Med; 2009 Oct; 50(10):1570-7. PubMed ID: 19793734
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Task-specific monitoring of nuclear medicine technologists' radiation exposure.
    Smart R
    Radiat Prot Dosimetry; 2004; 109(3):201-9. PubMed ID: 15254324
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiation absorbed dose estimates for oxygen-15 radiopharmaceuticals (H2(15)O, C15O, O15O) in newborn infants.
    Powers WJ; Stabin M; Howse D; Eichling JO; Herscovitch P
    J Nucl Med; 1988 Dec; 29(12):1961-70. PubMed ID: 3193210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 166Ho-DOTMP radiation-absorbed dose estimation for skeletal targeted radiotherapy.
    Breitz HB; Wendt RE; Stabin MS; Shen S; Erwin WD; Rajendran JG; Eary JF; Durack L; Delpassand E; Martin W; Meredith RF
    J Nucl Med; 2006 Mar; 47(3):534-42. PubMed ID: 16513624
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biokinetic models for the behaviour of carbon-14 from labelled compounds in the human body: can a single generic model be justified?
    Taylor DM
    Radiat Prot Dosimetry; 2004; 108(3):187-202. PubMed ID: 15031441
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Internal radionuclide radiation dosimetry: a review of basic concepts and recent developments.
    Zanzonico PB
    J Nucl Med; 2000 Feb; 41(2):297-308. PubMed ID: 10688115
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Organ doses and effective doses in pediatric radiography: patient-dose survey in Finland.
    Kiljunen T; Tietäväinen A; Parviainen T; Viitala A; Kortesniemi M
    Acta Radiol; 2009 Jan; 50(1):114-24. PubMed ID: 19096954
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 2007 recommendations of the ICRP change basis for estimation of the effective dose: what is the impact on radiation dose assessment of patient and personnel?
    Boetticher Hv; Lachmund J; Looe HK; Hoffmann W; Poppe B
    Rofo; 2008 May; 180(5):391-5. PubMed ID: 18438741
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Annals of the ICRP. A report of: doses to infants from ingestion of radionuclides in mothers' milk.
    International Commission on Radiological Protection
    Ann ICRP; 2004; 34(3-4):iii, 15-267, 269-80. PubMed ID: 16168243
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patient exposure and radiation risk in Bulgarian diagnostic nuclear medicine. I. Survey of diagnostic nuclear medicine procedures in Bulgaria in 1980.
    Poppitz R
    Nuklearmedizin; 1982 Jun; 21(3):85-91. PubMed ID: 7134004
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An update of radiopharmaceutical schedules in children.
    Smith T; Gordon I
    Nucl Med Commun; 1998 Nov; 19(11):1023-36. PubMed ID: 9861619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.